ADMA Biologics ADMA U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards
U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's u.s. federal, state and foreign net operating loss, credit carryforwards and other carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards?
- ADMA Biologics (ADMA) reported U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards of $64.43M in Q4 2025.